PharmaTher CEO Fabio Chianelli on Evolving Into Specialty Biotech Company Focused on Ketamine Nov 17, 2020
Amid Psychedelic Rush, Canadian Healthcare Professionals Have Waited 150 Days For Exemptions Nov 16, 2020
Cybin Comes To Market 3 Weeks After Closing the Largest Raise In Canadian Psychedelics History Nov 10, 2020
Havn Life Sciences CEO on Decriminalization of Psychedelics in Oregon and Washington D.C. Nov 8, 2020
